Ageing, cellular senescence and chronic kidney disease: experimental evidence.

Huishi Tan, Jie Xu, Youhua Liu
Author Information
  1. Huishi Tan: State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  2. Jie Xu: State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  3. Youhua Liu: State Key Laboratory of Organ Failure Research, National Clinical Research Center of Kidney Disease, Division of Nephrology, Nanfang Hospital, Southern Medical University, Guangzhou, China.

Abstract

PURPOSE OF REVIEW: Chronic kidney disease (CKD) is often viewed as an accelerated and premature ageing of the kidney, as they share common pathological features characterized by cellular senescence. In this review, we summarize the experimental evidence linking cellular senescence to the pathobiology of kidney ageing and CKD, and discuss the strategies for targeting senescent cells in developing therapeutics for ageing-related kidney disorders.
RECENT FINDINGS: Kidney ageing and CKD are featured with increased cellular senescence, an irreversible state of cell cycle arrest and the cessation of cell division. Senescent cells secrete a diverse array of proinflammatory and profibrotic factors known as senescence-associated secretory phenotype (SASP). Secondary senescence can be induced by primary senescent cells via a mechanism involving direct contact or the SASP. Various senolytic therapies aiming to selectively remove senescent cells in vivo have been developed. Senostatic approaches to suppress senescence or inhibit SASP, as well as nutrient signalling regulators are also validated in animal models of ageing.
SUMMARY: These recent studies provide experimental evidence supporting the notion that accumulation of senescent cells and their associated SASP is a main driver leading to structural and functional organ degeneration in CKD and other ageing-related disorder.

References

  1. Nature. 2020 Jul;583(7814):127-132 [PMID: 32555459]
  2. J Mol Cell Cardiol. 2007 Nov;43(5):571-9 [PMID: 17916362]
  3. Redox Biol. 2021 Jan;38:101813 [PMID: 33279869]
  4. Circ Res. 2021 Feb 19;128(4):492-507 [PMID: 33334122]
  5. J Cell Mol Med. 2021 Sep;25(18):8957-8972 [PMID: 34414658]
  6. Sci Rep. 2017 Nov 15;7(1):15678 [PMID: 29142250]
  7. Oxid Med Cell Longev. 2018 Nov 7;2018:4814928 [PMID: 30524656]
  8. Sci Transl Med. 2021 Jan 6;13(575): [PMID: 33408182]
  9. Ann Transl Med. 2021 Jun;9(12):979 [PMID: 34277779]
  10. Nat Rev Nephrol. 2021 Aug;17(8):512 [PMID: 34163041]
  11. Nat Rev Cancer. 2008 Jul;8(7):512-22 [PMID: 18574463]
  12. Redox Biol. 2017 Apr;11:297-311 [PMID: 28033563]
  13. Nature. 2003 Sep 11;425(6954):191-6 [PMID: 12939617]
  14. Front Genet. 2020 Aug 11;11:867 [PMID: 32849838]
  15. J Mol Biol. 2020 May 29;432(12):3661-3679 [PMID: 31887285]
  16. Science. 2004 Mar 26;303(5666):2011-5 [PMID: 14976264]
  17. Cell Metab. 2020 Nov 3;32(5):814-828.e6 [PMID: 32949498]
  18. Trends Cell Biol. 2020 Dec;30(12):919-922 [PMID: 32978041]
  19. Nature. 2011 Nov 02;479(7372):232-6 [PMID: 22048312]
  20. Trends Cell Biol. 2018 Jun;28(6):436-453 [PMID: 29477613]
  21. Aging Cell. 2021 Feb;20(2):e13317 [PMID: 33524231]
  22. EMBO J. 2004 Jun 16;23(12):2369-80 [PMID: 15152190]
  23. J Am Soc Nephrol. 2017 Oct;28(10):2838-2844 [PMID: 28790143]
  24. Science. 2002 May 17;296(5571):1276-9 [PMID: 11950998]
  25. Curr Mol Med. 2015;15(1):27-37 [PMID: 25601466]
  26. Aging Cell. 2021 Mar;20(3):e13318 [PMID: 33547862]
  27. Nature. 2009 Jul 16;460(7253):392-5 [PMID: 19587680]
  28. Nat Commun. 2017 Sep 4;8(1):422 [PMID: 28871086]
  29. J Cell Physiol. 2020 Dec;235(12):9773-9784 [PMID: 32437012]
  30. Nephrol Dial Transplant. 2020 May 1;35(5):773-781 [PMID: 32221606]
  31. Front Pharmacol. 2020 May 26;11:755 [PMID: 32528288]
  32. Cancer Res. 2017 Jun 1;77(11):2938-2951 [PMID: 28386016]
  33. Aging Cell. 2021 Jun;20(6):e13370 [PMID: 33957702]
  34. Biogerontology. 2019 Apr;20(2):171-189 [PMID: 30456590]
  35. Endocr Rev. 2015 Apr;36(2):174-93 [PMID: 25695404]
  36. EBioMedicine. 2019 Sep;47:446-456 [PMID: 31542391]
  37. Anal Bioanal Chem. 2020 Nov;412(28):8003-8014 [PMID: 32918173]
  38. Mech Ageing Dev. 2011 Oct;132(10):480-7 [PMID: 21855561]
  39. Cell. 2015 Mar 26;161(1):106-118 [PMID: 25815989]
  40. Sci Transl Med. 2021 May 19;13(594): [PMID: 34011625]
  41. J Intern Med. 2020 Nov;288(5):518-536 [PMID: 32686219]
  42. Ageing Res Rev. 2021 Sep;70:101412 [PMID: 34302996]
  43. Adv Exp Med Biol. 2018;1086:169-187 [PMID: 30232759]
  44. Aging Cell. 2021 Jul;20(7):e13407 [PMID: 34118180]
  45. J Pineal Res. 2016 Sep;61(2):230-40 [PMID: 27159033]
  46. Aging Cell. 2020 Nov;19(11):e13267 [PMID: 33219735]
  47. Aging Dis. 2021 Aug 1;12(5):1304-1322 [PMID: 34341710]
  48. J Am Soc Nephrol. 2018 Apr;29(4):1238-1256 [PMID: 29440280]
  49. Cell. 2006 Aug 11;126(3):503-14 [PMID: 16901784]
  50. Nature. 2014 May 22;509(7501):439-46 [PMID: 24848057]
  51. Pharmacol Ther. 2022 Jan;229:107983 [PMID: 34480962]
  52. Genes Dev. 2020 Dec 1;34(23-24):1565-1576 [PMID: 33262144]
  53. Circ Res. 2012 Jun 22;111(1):97-109 [PMID: 22723221]
  54. Nature. 2018 Mar;555(7698):570-571 [PMID: 32099149]
  55. Adv Chronic Kidney Dis. 2016 Jan;23(1):19-28 [PMID: 26709059]
  56. Methods Mol Biol. 2019;1896:203-230 [PMID: 30474850]
  57. Front Pharmacol. 2020 Dec 11;11:601325 [PMID: 33362554]
  58. Aging Cell. 2016 Jun;15(3):428-35 [PMID: 26711051]
  59. Aging (Albany NY). 2020 Jan 20;12(2):1272-1284 [PMID: 31959736]
  60. Front Pharmacol. 2020 Aug 20;11:1273 [PMID: 32973510]
  61. Aging (Albany NY). 2011 Nov;3(11):1110-9 [PMID: 22166671]
  62. Aging Cell. 2020 Apr;19(4):e13122 [PMID: 32196928]
  63. EBioMedicine. 2018 Oct;36:18-28 [PMID: 30279143]
  64. Aging (Albany NY). 2021 May 25;13(10):13380-13392 [PMID: 34035185]
  65. Nat Aging. 2021 Oct;1(10):870-879 [PMID: 34841261]
  66. Am J Physiol Renal Physiol. 2017 Sep 1;313(3):F621-F628 [PMID: 28615249]
  67. JAMA Intern Med. 2021 Oct 1;181(10):1359-1366 [PMID: 34459844]
  68. Nature. 2018 Sep;561(7721):45-56 [PMID: 30185958]
  69. Clin Nutr. 2010 Jun;29(3):406-12 [PMID: 20044182]
  70. Ther Adv Chronic Dis. 2020 Oct 13;11:2040622320964125 [PMID: 33133476]
  71. J Cell Sci. 2000 Oct;113 ( Pt 20):3613-22 [PMID: 11017877]
  72. Science. 2021 Jan 15;371(6526):265-270 [PMID: 33446552]
  73. Mol Med Rep. 2021 Jan;23(1): [PMID: 33179086]
  74. Dev Cell. 2014 Dec 22;31(6):722-33 [PMID: 25499914]
  75. Physiol Rep. 2021 Jan;9(2):e14696 [PMID: 33463897]
  76. Aging Cell. 2019 Oct;18(5):e13004 [PMID: 31318148]
  77. Vet Pathol. 2020 Nov;57(6):747-757 [PMID: 32744147]
  78. Sci Transl Med. 2021 Jan 27;13(578): [PMID: 33504653]
  79. Aging (Albany NY). 2021 Feb 17;13(5):6330-6345 [PMID: 33612480]
  80. Int J Mol Sci. 2018 Sep 15;19(9): [PMID: 30223594]
  81. Aging Cell. 2020 Dec;19(12):e13270 [PMID: 33166065]
  82. Cell Stem Cell. 2020 Jun 4;26(6):817-831 [PMID: 32502402]
  83. Cell. 2013 Nov 21;155(5):1104-18 [PMID: 24238962]
  84. Sci Rep. 2017 May 15;7(1):1900 [PMID: 28507307]
  85. Lancet. 2015 Feb 14;385(9968):658-661 [PMID: 25468151]
  86. Nat Rev Mol Cell Biol. 2021 Feb;22(2):75-95 [PMID: 33328614]
  87. Nature. 1997 Nov 6;390(6655):45-51 [PMID: 9363890]
  88. Exp Ther Med. 2020 Aug;20(2):1245-1252 [PMID: 32765665]
  89. Science. 2005 Sep 16;309(5742):1829-33 [PMID: 16123266]
  90. Aging Cell. 2021 Apr;20(4):e13337 [PMID: 33728821]
  91. Cell. 2006 Jan 27;124(2):315-29 [PMID: 16439206]
  92. Nature. 2003 Nov 13;426(6963):194-8 [PMID: 14608368]
  93. Am J Physiol Renal Physiol. 2008 Jun;294(6):F1265-72 [PMID: 18287400]

Grants

  1. R01 DK064005/NIDDK NIH HHS

MeSH Term

Aging
Animals
Cellular Senescence
Female
Humans
Kidney
Male
Renal Insufficiency, Chronic
Senescence-Associated Secretory Phenotype

Word Cloud

Created with Highcharts 10.0.0senescencekidneycellsCKDageingcellularsenescentSASPexperimentalevidenceageing-relatedcellPURPOSEOFREVIEW:ChronicdiseaseoftenviewedacceleratedprematuresharecommonpathologicalfeaturescharacterizedreviewsummarizelinkingpathobiologydiscussstrategiestargetingdevelopingtherapeuticsdisordersRECENTFINDINGS:KidneyfeaturedincreasedirreversiblestatecyclearrestcessationdivisionSenescentsecretediversearrayproinflammatoryprofibroticfactorsknownsenescence-associatedsecretoryphenotypeSecondarycaninducedprimaryviamechanisminvolvingdirectcontactVarioussenolytictherapiesaimingselectivelyremovevivodevelopedSenostaticapproachessuppressinhibitwellnutrientsignallingregulatorsalsovalidatedanimalmodelsSUMMARY:recentstudiesprovidesupportingnotionaccumulationassociatedmaindriverleadingstructuralfunctionalorgandegenerationdisorderAgeingchronicdisease:

Similar Articles

Cited By